Adjuvant Chemotherapy Customisation Based on ERCC1 and TS mRNA Levels Does Not Improve Efficacy in Resected NSCLC
Findings from the ITACA study in patients with completely resected, stage II-IIIA non-small cell lung cancer
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
Findings from the ITACA study in patients with completely resected, stage II-IIIA non-small cell lung cancer
It is indicated for the treatment of adult patients who have received prior treatment with three or more kinase inhibitors, including imatinib
Findings from a phase II study in second-line treatment
New indication concerns the first-line treatment of adult patients with HER2-negative advanced or metastatic gastric, GEJ or oesophageal adenocarcinoma
Findings from the largest study to measure anti-SARS-CoV-2 antibody levels after vaccination in patients with haematological and solid malignant tumours
Evidence for efficacy is based on the results from the COSMIC-311 study
Findings from a phase II single-arm investigator-initiated study
It is intended for the treatment of patients with RET fusion positive NSCLC
Findings from the IMCgp100-202 study
Findings from the Vax-On study show a favourable safety profile of mRNA-based COVID-19 vaccine in patients with solid tumours during active anticancer treatment
Evidence for efficacy is based on the results from the innovaTV 204 study
Findings from the PANAMA study (AIO KRK 0212)
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.